Update on the intriguing roles of AQP4 expression and redistribution in the progression and treatment of glioma
Yu-Long Lan Shuang Zou Ruoli Chen a Department of Neurosurgery,Second Affiliated Hospital,School of Medicine,Zhejiang University,Hangzhou,Zhejiang,Chinab Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases,Hangzhou,Zhejiang,Chinac Clinical Research Center for Neurological Diseases,Hangzhou,Zhejiang,Chinad Key Laboratory of Neuropharmacology and Translational Medicine,School of Pharmaceutical Science,Zhejiang Chinese Medical University,Hangzhou,Chinae School of Pharmacy and Bioengineering,Keele University,Staffordshire,UK
DOI: https://doi.org/10.1080/07853890.2024.2401111
IF: 5.348
2024-09-09
Annals of Medicine
Abstract:Aquaporin 4 (AQP4) is abundant in the human brain and has an important role in brain homeostasis and diseases. AQP4 expression has been found to be associated with glioma malignancies. However, the complete understanding of the biological processes and curative importance of AQP4 in glioma remains unclear. The impact of AQP4 subcellular mislocalization on glioma progression and the precise mechanisms regarding AQP4 translocation in glioma need further investigation. In this review, we update recent findings about disturbed AQP4 expression in glioma and explore targeting AQP4 to modulate the glioma progression. Thereafter we discuss some possible mechanisms of action of AQP4 translocations in glioma. The present article offers an appropriate introduction to the potential involvement of AQP4 in the emergence and progression of glioma. Both comprehensive research into the mechanisms and systematically intervention studies focusing on AQP4 are essential. By embracing this strategy, we can obtain a new and insightful outlook on managing cancerous glioma. Although the observations summarized in this review should be confirmed with more studies, we believe that they could provide critical information for the design of more focused research that will allow for systematic and definitive evaluation of the role of AQP4 in glioma treatments.
medicine, general & internal